Publication | Closed Access

Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI

Hematological MalignancyWithdrawal SyndromeChronic Myeloid LeukemiaMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyPharmacologyPharmacotherapyOncologyMyeloid Neoplasia